Section 7.4: Opioid 10-day Initial Supply Limit & PMP Mandatory Queries

Section 7.4: Opioid 10-day Initial Supply Limit & PMP Mandatory Queries

Quick Answer: For acute pain, Texas law limits what a practitioner may prescribe — not what a pharmacist is absolutely forbidden to dispense. Under Tex. Health & Safety Code §481.07636, a practitioner may not issue an opioid prescription exceeding a 10-day supply or provide a refill. Acute pain excludes chronic pain, cancer care, hospice/end-of-life care, and palliative care; sickle cell is not on that exclusion list. FDA-approved opioids issued for substance addiction treatment are also outside the 10-day rule. A dispenser has statutory safe harbor for dispensing or refusing to dispense an exceeding prescription, while still owing corresponding responsibility. Separately, pharmacists and prescribers must query the Texas PMP for OBBC drugs (opioids, benzodiazepines, barbiturates, carisoprodol); cancer, sickle cell, or hospice noted in the prescription record is a PMP exemption, not a 10-day exemption.

The 10-Day Rule Is a Practitioner Prescribing Limit

Texas enacted §481.07636 in response to opioid overdose risk. The statute's operative duty is aimed at the prescriber. For the treatment of acute pain, a practitioner may not: (1) issue a prescription for an opioid in an amount that exceeds a 10-day supply; or (2) provide for a refill of an opioid. Memorize that framing for the MPJE: the prohibition is on issuing an exceeding acute-pain opioid prescription, not a blanket criminal ban that says "a pharmacist may never dispense more than 10 days for acute pain."

The Texas Medical Board has interpreted the statute to mean a practitioner may write an opioid for up to 10 days without a refill. The patient may return for follow-up and receive another up-to-10-day opioid prescription for the same acute episode; the law does not cap how many separate follow-up prescriptions may be written over time. What it does forbid is authorizing refills on an acute-pain opioid prescription and writing a single acute-pain opioid prescription for more than a 10-day supply.

Defining Acute Pain (and What the Definition Excludes)

§481.07636(a) defines acute pain as the normal, predicted physiological response to a stimulus such as trauma, disease, and operative procedures. Acute pain is time-limited. The term does not include:

1. Chronic pain
2. Pain treated as part of cancer care
3. Pain treated as part of hospice or other end-of-life care
4. Pain treated as part of palliative care

Exam trap — sickle cell: Sickle cell disease is not listed in §481.07636(a) as an exclusion from the acute-pain definition. Do not treat sickle cell as a statutory carve-out from the 10-day prescribing limit. (Sickle cell does matter for PMP-query exemptions — that is a different statute, covered below.)

MAT Carve-Out from the 10-Day Limit

Under §481.07636(c), the 10-day / no-refill limits do not apply to a prescription for an opioid approved by the FDA for the treatment of substance addiction when the practitioner issues it for that purpose (medication-assisted treatment). A buprenorphine product prescribed for opioid use disorder is not constrained by the acute-pain 10-day rule; the same product prescribed purely for acute pain would be.

Dispenser Safe Harbor — Do Not Teach an Absolute Dispense Ban

§481.07636(d) is the pharmacist-focused provision most often misstated on exam prep materials: A dispenser is not subject to criminal, civil, or administrative penalties for dispensing or refusing to dispense a controlled substance under a prescription that exceeds the limits in subsection (b).

That means:

• The duty to stay within 10 days / no refill for acute pain is primarily on the practitioner.
• If a pharmacist receives an acute-pain opioid prescription that appears to exceed 10 days, the pharmacist is not automatically subject to §481.07636 penalties merely for filling it — and is also protected if they refuse to fill it.
• Safe harbor is not a license to ignore professional judgment. Pharmacists still owe corresponding responsibility under federal and Texas controlled-substance law. Contacting the prescriber, clarifying whether the indication is truly acute pain versus an excluded category (cancer, hospice, palliative, chronic), documenting the conversation, and refusing when legitimacy or patient safety is unresolved remain sound practice.

Exam Tip: Wrong answer patterns often say "the pharmacist may not dispense more than a 10-day supply for acute pain" as an absolute prohibition. The better answer ties the limit to the practitioner, cites dispenser safe harbor, and still expects corresponding-responsibility diligence.

The Texas PMP and Mandatory OBBC Queries

The Texas Prescription Monitoring Program (PMP), administered by the TSBP, collects outpatient Schedule II–V controlled-substance dispensing data. Separately from the 10-day prescribing statute, Texas requires both prescribing practitioners and dispensing pharmacists to query the patient's PMP history before prescribing or dispensing certain drugs — commonly taught as mandatory for "every patient, every time" on initial fills and subsequent fills for the covered classes.

The "OBBC" Mandatory Drug Classes

The mandatory query does not cover every controlled substance. It applies to four classes memorized as OBBC:

1. Opioids (e.g., hydrocodone, oxycodone, tramadol, fentanyl)
2. Benzodiazepines (e.g., alprazolam, clonazepam, diazepam, lorazepam)
3. Barbiturates (e.g., phenobarbital, butalbital)
4. Carisoprodol (Soma)

Document that the PMP was checked in the dispensing system. Stimulants (e.g., mixed amphetamine salts / Adderall) and many other non-OBBC controlled substances are not subject to this mandatory query rule, even when Schedule II — checking may still be good practice, but it is not the OBBC legal mandate.

PMP Exemptions Are Not the Same as 10-Day Exclusions

Under Tex. Health & Safety Code §481.0765 and related TSBP rules (including 22 TAC §315.15), a prescriber or pharmacist is exempt from the mandatory PMP query when, among other situations:

1. Cancer, sickle cell, or hospice — the patient has been diagnosed with cancer or sickle cell disease, or is receiving hospice care, and that status is clearly noted in the prescription record.
2. Inpatient / certain facility administration — the drug is administered to a patient who is an inpatient in a hospital, or in specified outpatient encounter settings such as an emergency department or ambulatory surgical center, as provided by statute/rule.
3. Technological failure — a good-faith attempt to access the PMP fails due to hardware, software, or network failure beyond the practitioner's or pharmacist's control, with documentation of the attempt.

Keep the lists separate on the exam:

Pharmacy PMP Transmission Timelines

Dispensing pharmacies must transmit Schedule II–V controlled-substance prescription data to the PMP no later than the next business day after the prescription is completely filled. If no controlled substances are dispensed on a business day, applicable zero-reporting rules still apply under TSBP requirements. Late or missing transmissions can support administrative action against the pharmacy permit and the pharmacist-in-charge.

Enforcement Mindset for the MPJE

TSBP and prescriber boards actively monitor PMP query and reporting compliance. Failure to perform a mandatory OBBC query is unprofessional conduct and can support fines or license action. Separately, corresponding responsibility still applies to suspicious opioid prescriptions even when §481.07636(d) protects the dispenser from penalties under the 10-day statute itself. Know which statute you are being asked about: prescribing limit, dispenser safe harbor, or PMP mandate.